Clinical Trials Directory

Trials / Completed

CompletedNCT00824824

Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Massachusetts Eye and Ear Infirmary · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

We have completed a study in which we examined the response of the retinal circulation to changes in posture from sitting to lying down in patients with primary open angle glaucoma (POAG). This alteration in position produces changes in the local blood pressure at the entrance to the retinal vasculature. In a healthy retina, the vasculature adapts by dilating and constricting in order to maintain a steady blood flow rate. In an eye with POAG, this often does not occur. As a result, there are large fluctuations in blood flow which may produce the retinal neuronal damage associated with glaucoma. The purpose of this study is to demonstrate that topical anti-glaucoma treatments with agents that have vasoactive as well as IOP-lowering effects can have a beneficial effect on maintaining a steady retinal blood flow rate even when there are changes in local blood pressure.

Conditions

Interventions

TypeNameDescription
DRUGDorzolamide 2%-timolol 0.5%BID OU for 6 weeks
DRUGBrimonidine 0.2%-0.5% timolol 0.5BID OU for 6 weeks

Timeline

Start date
2009-01-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2009-01-19
Last updated
2017-04-04
Results posted
2016-10-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00824824. Inclusion in this directory is not an endorsement.

Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG) (NCT00824824) · Clinical Trials Directory